已收盘 11-20 16:00:00 美东时间
-0.025
-2.16%
Medicus Pharma (NASDAQ: MDCX) regained Nasdaq listing compliance after raising $4.25 million in equity and exchanging $10.5 million in debt.
11-19 20:31
Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, today
05-28 20:19
Medicus Pharma stock surged then slipped after the Phase 2 trial showed a 73% clearance rate for its skin cancer treatment.
03-05 22:13
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics
01-05 20:35
Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics
2025-12-01 20:42